Comments
Dr Reddy’s Laboratories today said it has received an establishment inspection report (EIR) from the US health regulator after audit of its UK facility. “With regard to the audit of our API Mirfield plant, UK, we would now like to inform you that we have received an establishment inspection report (EIR) from the USFDA, for the above-referred facility, indicating closure of the audit,” Dr Reddy’s said in a regulatory filing.
The USFDA issues an EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection. In September last year, the US health regulator had made three observations after inspecting Dr Reddy’s Laboratories’ API Mirfield plant, UK. Shares of Dr Reddy’s Laboratories were trading at Rs 2,170.35 apiece on BSE, up 1.71 per cent from previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.